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Abstract
Background: Low back pain is highly prevalent and one of the most common causes of disability in U.S. armed
forces personnel. Currently, no single therapeutic method has been established as a gold standard treatment for
this increasingly prevalent condition. One commonly used treatment, which has demonstrated consistent positive
outcomes in terms of pain and function within a civilian population is spinal manipulative therapy provided by
doctors of chiropractic. Chiropractic care, delivered within a multidisciplinary framework in military healthcare
settings, has the potential to help improve clinical outcomes for military personnel with low back pain. However, its
effectiveness in a military setting has not been well established. The primary objective of this study is to evaluate
changes in pain and disability in active duty service members with low back pain who are allocated to receive
usual medical care plus chiropractic care versus treatment with usual medical care alone.
Methods/design: This pragmatic comparative effectiveness trial will enroll 750 active duty service members with
low back pain at three military treatment facilities within the United States (250 from each site) who will be
allocated to receive usual medical care plus chiropractic care or usual medical care alone for 6 weeks. Primary
outcomes will include the numerical rating scale for pain intensity and the Roland-Morris Disability Questionnaire at
week 6. Patient reported outcomes of pain, disability, bothersomeness, and back pain function will be collected at
2, 4, 6, and 12 weeks from allocation.
Discussion: Because low back pain is one of the leading causes of disability among U.S. military personnel, it is
important to find pragmatic and conservative treatments that will treat low back pain and preserve low back
function so that military readiness is maintained. Thus, it is important to evaluate the effects of the addition of
chiropractic care to usual medical care on low back pain and disability.
Trial registration: The trial discussed in this article was registered in ClinicalTrials.gov with the NCT01692275 Date
of registration: 6 September 2012
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Background
Low back pain (LBP) is well recognized as a prevalent
and burdensome health problem in both military and
civilian populations [1, 2]. It is also one of the most
common reasons why members of the U.S. armed forces
seek medical care [3, 4]. LBP, common in both deployed
and non-deployed military personnel [5], is also among
the most likely conditions to interrupt combat duty [2,
6]. In army personnel, LBP represents the highest 5-year
risk factor for permanent disability [7].
Because of the combined costs associated with per-
sonal suffering, healthcare, and disability expenditures,
and the resulting impaired capacity of personnel to con-
duct military operations, LBP has been characterized as
“the silent military threat” [8, 9]. Development of a more
effective, early treatment that prevents chronicity and re-
duces recurrence is likely to mitigate some of the dele-
terious effects of LBP on individuals and the military
healthcare system.
In the United States, the chiropractic profession con-
tains more than 70,000 actively licensed practitioners
[10] who specialize in conservative treatment for muscu-
loskeletal conditions with a special focus on spinal
health [11]. At least 7.5 % of the U.S. population seeks
chiropractic care each year, representing over 190 mil-
lion patient visits annually [12, 13]. The care offered by
doctors of chiropractic (DCs) is consistently rated highly
by patients in studies assessing satisfaction [14–17]. Ran-
domized controlled trials (RCTs) have demonstrated that
chiropractic care and its signature treatment, spinal ma-
nipulation, is an effective conservative care option for
patients with LBP [18–21]. Chiropractic care or spinal
manipulation is also endorsed as an evidence-based, cost
effective, conservative treatment option in the clinical
practice guidelines for patients with acute, subacute, and
chronic LBP [22–24].
DCs provide care in private practice and in multidis-
ciplinary healthcare settings, including Veterans Affairs
and military health treatment facilities [25, 26]. Cur-
rently, chiropractic care is available at 65 military health
treatment facilities within the United States and inter-
nationally [27].
Goertz et al. conducted a pilot RCT comparing the ef-
fectiveness of chiropractic care plus standard medical
care with standard medical care alone for active duty
military personnel with acute LBP [28]. This study
reported clinically and statistically significant greater im-
provement in pain and disability in the group including
chiropractic care. However, the study was conducted at
a single military installation with a relatively small
sample (n = 91). This paper describes a larger scale, mul-
tisite, comparative effectiveness study at three geograph-
ically and demographically diverse U.S. military medical
treatment facilities. Because chiropractic care for LBP in
the military is delivered within a multidisciplinary frame-
work of care, rather than as a single system of care, the
study is focused on the comparative effectiveness of
chiropractic care plus usual medical care with usual
medical care alone, in a pragmatic design.
Specific aims
The primary aim of this pragmatic comparative effect-
iveness study is to compare pain and disability of active
duty military personnel with LBP who are treated with
chiropractic care and usual medical care compared with
those treated with usual medical care alone. We
hypothesize that those allocated to receive both chiro-
practic care and usual medical care will show greater
reduction in pain and disability than those receiving
usual medical care alone.
Secondary aims explore the effects of adding chiro-
practic care to usual medical care on healthcare
utilization, medication use, and quality of life.
Methods
Overview
The Assessment of Chiropractic Treatment for LBP in
Active Duty Military Personnel (ACT 1) is a pragmatic,
prospective, multisite, parallel group comparative effect-
iveness study with adaptive allocation [29–31]. ACT 1 is
being conducted at Naval Medical Center San Diego,
California (NMCSD), Naval Hospital Pensacola, Florida
(NHP), and Walter Reed National Military Medical
Center (WRNMMC), Bethesda, Maryland. Two hundred
and fifty participants with chronic, subacute, or acute
non-surgical LBP are being enrolled at each site (total of
750).
Participants meeting eligibility criteria are allocated to
one of two treatment groups: usual medical care (UMC)
plus chiropractic care and UMC alone. The active care
phase of the study is 6 weeks from group allocation.
Patient-reported outcomes (PROs) are assessed at base-
line (prior to randomization) and at 2, 4, 6, and 12 weeks
from allocation with the primary endpoint at 6 weeks
(Fig. 1).
The trial is managed through the Submission Tracking
and Reporting System (STaRS), a comprehensive web ap-
plication developed by the Palmer Center for Chiropractic
Research (PCCR) with a dual purpose of collecting out-
come assessments for study participants and serving as a
secure electronic data capture and clinical trial manage-
ment system for study personnel. The STaRS application
is available for participants to access 24 hours a day
throughout the duration of the trial. Study staff use STaRS
for data entry, confirmation of participant eligibility, and
study event reporting. STaRS also provides real-time re-
ports for study management.
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Trial organization
The research team comprises individuals from three col-
laborating institutions: the RAND Corporation, the
PCCR, and the Samueli Institute. The RAND Corpor-
ation manages the financial aspects, overall administra-
tion, and Institutional Review Board (IRB) issues of the
grant award, as well as required deliverables to the De-
partment of Defense (DoD) program officer. The
Samueli Institute advises on processes for conducting
research within the military and ensures compliance
with the entities that regulate the conduct of human
subjects’ clinical research within the DoD to include the
U.S. Army Medical Research and Material Command
Human Research Protection Office and the Army’s Clin-
ical Investigation Regulatory Office.
Investigators from the PCCR are responsible for devel-
oping, implementing, and managing the trial at each of
the three sites. Each trial site includes an active duty
United States Naval or Army medical officer serving as
principal investigator (PI), one or two DCs, and one
PCCR site Project Manager (PM) locally stationed at the
military treatment facility (MTF). The PM is responsible
for day-to-day trial implementation at the respective
MTF including the conduct of recruitment activities,
participant tracking, and communication. A lead PM
oversees trial operations at all three sites, acts as a
liaison between the sites and trial co-investigators, and
ensures protocol adherence and fidelity across sites. A
central trial clinician reviews and monitors all adverse
events.
Fig. 1 ACT 1 study flow chart
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Clinical sites
Participating clinical sites are MTFs that had an already
established chiropractic program. DCs delivering patient
care for trial participants are civilians who were
contracted on a full-time basis by the DoD within the
MTF 15–20 years prior to initiation of the study. Further
information about each site is briefly described below.
Naval Hospital Pensacola (NHP)
NHP and its nearby associated naval branch clinics pro-
vide healthcare services to active duty military personnel
in the Pensacola, Florida region. Chiropractic care is
available to active duty personnel at the Naval Branch
Health Clinic Naval Air Technical Training Command.
Chiropractic services are part of the Sports Medicine
and Rehabilitative Therapy Clinic and have been avail-
able since September 2003. A single DC provides care
for trial participants at the Naval Air Technical Training
Command branch clinic.
Walter Reed National Military Medical Center (WRNMMC)
WRNMMC, located in Bethesda, Maryland, is the largest
U.S. military medical center, providing services to over 1
million beneficiaries per year [32]. The chiropractic
clinic at WRNMMC is located within the Department of
Orthopedics and Rehabilitation and provides care to
active duty service members with musculoskeletal condi-
tions including service members with combat-related in-
juries. WRNMMC established chiropractic services in
1998. Two DCs provide care to trial participants at this
site.
Naval Medical Center San Diego (NMCSD)
NMCSD is a large military healthcare system located in
coastal southern California serving U.S. military
personnel stationed at several surrounding military
bases. NMCSD provides chiropractic care for active duty
personnel as a special service of the Physical Therapy
Department. Chiropractic services have been available at
NMCSD since 2003. A single DC provides care to trial
participants within the branch clinic at North Island, on
Naval Base Coronado.
Regulatory approvals
The trial protocol received ethics approvals from the fol-
lowing five Institutional Review Boards: Palmer College
of Chiropractic (#2010G137), RAND Corporation
(#2010-0782), NMCSD (#NMCSD.2012.0022, IRB of
record: Naval Medical Center San Diego, California),
NHP (#NHPC.2012.0002, IRB of record: Naval Medical
Center Portsmouth, Virginia), and WRNMMC (#369462,
IRB of record: Walter Reed National Military Medical
Center Bethesda, Maryland). The study protocol was
also approved by the U.S. Army Medical Research and
Material Command Human Research Protection Office
and the Clinical Investigation Regulatory Office. All
study investigators have completed training in the pro-
tection of human subjects as required by the respective
collaborating institutions.
Prior to study commencement, the collaborating in-
vestigative institutions also established a Cooperative Re-
search and Development Agreement (CRADA) with
each of the three participating MTFs. Final approval of
the CRADA occurred in June 2012 and was renewed in
April 2015. A data sharing agreement and systems se-
curity verification, under the auspices of TRICARE Man-
agement Activity, were established between the MTFs
and the ACT 1 collaborating institutions (RAND Cor-
poration and PCCR).
Recruitment procedures
Active duty participants aged 18–50 years (inclusive)
reporting acute, subacute, or chronic LBP who are able
to provide voluntary written informed consent are eli-
gible for this trial. Participants are ineligible if they have
knowledge of a pending absence through the 6-week ac-
tive treatment phase. Such absences could include a
planned leave, deployment, temporary duty assignment,
or permanent change of station. Participants unwilling
to be allocated to either intervention arm are also ineli-
gible. A detailed description of the inclusion/exclusion
criteria is summarized in Table 1.
Patients with LBP enter the military healthcare
delivery system through multiple pathways. Thus, the
investigative team identified department clinics likely to
diagnose or manage patients with LBP within each MTF
and requested their assistance with recruitment efforts.
Command support (permission) was obtained prior to
study recruitment, from each respective department, to
post IRB-approved study advertisements and recruit
study participants. At WRNMMC, command support
was obtained from the internal medicine, physical ther-
apy, neurosurgery, and physical medicine and rehabilita-
tion departments. At NHP, command support was
received from the Department of Family Medicine, the
Department of Orthopedics, and three branch clinics:
Naval Air Station Pensacola branch clinic, Naval Air
Technical Training Center, and Corry Station. At
NMCSD, command support was obtained from the De-
partment of Orthopedics, Naval Branch Health Clinics
Miramar, Naval Base San Diego and Coronado, and the
NMCSD Military Health Center.
Participant screening
Trial participants are recruited via either self-referral or
referral from a healthcare provider. IRB-approved
recruitment materials are placed in patient waiting
rooms and other approved areas within each MTF. In
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either recruitment method, participants must meet all
clinically related eligibility criteria determined at exam
and general criteria confirmed by the PM during the
baseline interview. Individuals who do not meet all study
eligibility criteria are excluded. Responses to the baseline
eligibility interview and eligibility criteria obtained from
the examining clinician are entered and electronically
stored in STaRS.
Interested participants meet with the PM, who initiates
the informed consent process in a private setting. The
PM reviews the informed consent document, study flow
chart, and specific visit activities with the participant. In-
dividuals have the opportunity to read the informed con-
sent document and ask questions about participation.
Those wishing to participate sign the written informed
consent document. Following the consent process, a
baseline interview is conducted to obtain basic demo-
graphic information to screen for non-clinically deter-
mined eligibility criteria. After the baseline interview is
submitted, STaRS assigns each participant a unique
study number. Eligible participants are also assigned a
temporary password to complete online assessments.
Initially eligible participants undergo a clinical evalu-
ation of their low back by the healthcare provider who
manages the condition (that is, a neurologist, physiatrist,
or internist), a primary care provider, or an Independent
Duty Corpsman. During the evaluation, the provider
renders a professional opinion regarding clinically deter-
mined eligibility criteria such as whether or not the LBP
is related to the musculoskeletal system, the need for
additional diagnostic testing, and the existence of condi-
tions posing a contraindication to spinal manipulation
(such as acute spinal fracture or cauda equina syn-
drome). Eligibility information obtained from the clinical
evaluation is documented by the provider on a paper
form and provided to the PM, who enters the informa-
tion into STaRS to determine eligibility. Alternatively,
the LBP evaluation may be performed prior to an
individual’s meeting with a PM as part of the patient’s
standard of care.
Baseline assessment
Prior to allocation, all eligible participants complete a
baseline assessment consisting of demographic informa-
tion, expectations of care, and a series of PRO question-
naires that measure current pain intensity, the impact of
the current LBP on functional status and quality of life,
and self-reported medication use for LBP. The baseline
assessment is conducted on dedicated study computers.
Participants access the baseline assessment questions
by logging into STaRS using their email address as their
username and the temporary password assigned by
STaRS. STaRS requires all participants to change their
Table 1 Eligibility criteria
Inclusion criteria Rationale
Age≥ 18 and≤ 50 Age range of most active duty U.S.
military personnel
Acute, subacute, or chronic low
back pain
Low back pain commonly treated
by primary care and chiropractic
providers
Ability to provide voluntary written
informed consent
Able to comprehend study details;
able to make decisions without
limitations or impairment
Active duty status at one of the
three participating military
treatment facilities
Chiropractic care available only to
active duty personnel at U.S.
military treatment facilities
Exclusion criteria
LBP from a non-musculoskeletal
source (pain from a visceral
condition[s])
Care outside study scope needed;
potential to confound health
outcomes
Co-morbid pathology that may
directly impact spinal pain
Care outside study scope needed;
potential to confound health
outcomes
Recent spinal fracture (within the
last 8 weeks)
May influence ability to measure
pain-related health outcomes;
safety concern
Recent spinal surgery (within the
last 12 weeks)
Potential to confound health
outcomes due to natural history or
from potential complications
Spinal or paraspinal tumor(s) Care outside study scope needed




Potential to confound health
outcomes
Contraindication(s) for spinal
manipulation of the lumbar spine
and pelvis (unstable spinal
segments, cauda equina syndrome)
Care outside study scope needed
Pregnancy or plans to become
pregnant within active treatment
period
Potential to confound health
outcomes
Diminished/altered mental capacity May prohibit informed consent or
compromise safety or compliance
with study procedures
Use of spinal manipulative care for
any reason within the past month
Prevent carryover effects from
recent chiropractic care
Significant/severe osteoporosis Potential to confound health
outcomes; care outside study
scope may be needed
Unwilling to provide phone and
electronic contact information
Compromises ability to adhere to
study protocol
Unable to confirm availability
during the active treatment period
due to known deployment, orders
for a distant duty assignment, or
other absence
Compromises ability to adhere to
study protocol
Does not agree to be enrolled
regardless of group assignment




Potential to confound health
outcomes
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password upon initial login, which is used to complete
future online assessments.
Allocation
Participants remaining eligible after completing: 1) the
consent process, 2) baseline interview, 3) clinical evalu-
ation, and 4) baseline assessment are allocated to a treat-
ment group. Allocation occurs within STaRS via an
adaptive computer-generated minimization algorithm
programmed to balance group assignment on the factors
of sex (M, F), age (18 to <30, 30 to 50), LBP duration
(<1 month, 1–3months, >3 months), and baseline Nu-
meric Rating Scale (0–5, 6–10) measurement (worse
pain in past 24 hours). Participants are allocated to one
of two groups: 1) UMC or 2) UMC plus chiropractic
care. PMs, participants, and all study personnel are un-




In this pragmatic trial, UMC includes any care recom-
mended or prescribed by a non-chiropractic military
healthcare provider for the purpose of managing/treating
LBP. UMC may include education about a condition,
self-management advice, and pharmacologic pain man-
agement. Physical therapy and referral to a pain clinic
may also be prescribed as a component of UMC. UMC
providers report prescription medication class, referrals,
and/or self-care recommendations. Participants allocated
to the UMC group are asked by study personnel to avoid
receiving chiropractic care for 6 weeks unless otherwise
directed by their healthcare provider.
Usual medical care plus chiropractic care
Participants allocated to this group continue with pre-
scribed UMC as described above and also receive up to
12 chiropractic visits during the 6-week active care
period. Chiropractic treatment frequency, duration, and
procedures are determined individually based on the
participant’s condition, response to care, scheduling
availability, and other factors pertinent to the case.
The primary therapeutic procedures delivered by DCs
for LBP are thrust or non-thrust spinal manipulation in
the low back and adjacent regions [33]. Treatment deci-
sions regarding manipulation type, location, and direc-
tion are based on the LBP diagnosis and concurrent
diagnoses. Other factors that inform treatment decisions
include patient preference, prior response to care (if
known), the presence or absence of local tenderness,
paraspinal muscle hypertonicity, spinal joint hypomobi-
lity, positions of relief and/or provocation, and imaging
findings (for example, spinal curvatures, congenital
anomalies). Other therapeutic procedures delivered by
the DC may include rehabilitative exercise, manual ma-
nipulation of upper and lower extremity joints and other
spinal regions, interferential current therapy, ultrasound
therapy, cryotherapy, heat therapy, and manual myofas-
cial therapies.
Outcome measures
PROs are collected at 2, 4, 6, and 12 weeks from alloca-
tion (Table 2). The primary endpoint is at 6 weeks and
the secondary endpoint is at 12 weeks.
Primary outcome measures
The co-primary outcome measures are the Numeric Rat-
ing Scale (NRS) for average pain intensity during the past
week and the Roland-Morris Disability Questionnaire
(RMDQ). The NRS has excellent metric properties, is
commonly used in RCTs studying LBP [34, 35], and has
been demonstrated as a valid and reliable measure [36].
Participants are asked to rate their average level of LBP
during the past week on an ordinal 11-box scale (0 = no
LBP; 10 = worst possible LBP). The RMDQ is a reliable
and valid LBP-related disability assessment instrument
commonly used in clinical research [37, 38]. Containing
24 questions, it is considered sensitive to disability-related
changes in patients with LBP [39–41].
Secondary outcome measures
Secondary outcome measures include the NRS of the
worst LBP intensity during the past 24 hours, the Back
Pain Functional Scale, bothersomeness of symptoms, Pa-
tient Reported Outcomes Measurement Information
System (PROMIS)-29 variables, medication use, and
healthcare utilization.
The Back Pain Functional Scale is a 12-question sur-
vey assessing functional status. Each question is an-
swered using a 6-point scale (0 = unable to perform
activity and 5 = no difficulty), resulting in scores ranging
from 0 to 60 where the higher scores are equal to better
functional status [41]. Bothersomeness of symptoms as-
sociated with LBP is measured by asking the patient to
rate the bothersomeness of LBP during the past week,
measured on a 1 to 5 scale (1 = not at all bothersome
and 5 = extremely bothersome) [42, 43].
The PROMIS-29 is a set of questions that measure de-
pression, anxiety, physical function, pain interference, fa-
tigue, sleep disturbance, and satisfaction in social roles
[44]. The PROMIS-29 instrument contains 29 questions;
4 items from each primary domain plus a single pain in-
tensity rating. This outcome instrument is administered
at baseline and at weeks 6 and 12 [45–47]. Perceived
global LBP improvement is assessed using a question
adapted from a study investigating the effect of expecta-
tions on patients with LBP [48]. Participants are asked
to rate their perceived LBP improvement on a 7-point
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scale (0 = completely gone to 6 =much worse) at weeks
2, 4, and 6.
Participants are asked to indicate the type of health-
care providers who have treated their current episode of
LBP and indicate how often they took pain relieving
medication (both prescription and/or over-the-counter)
during the past week. Choices are 0 days, 1–2 days, 3–4
days, 5–6 days, or 7 days.
Data collection and management
Data collection
This trial uses paper data collection forms, electronic
data capture through STaRS, and data abstracted from
the participant’s electronic medical record.
The STaRS home page provides all users the same
login that, upon validation, directs them to the appropri-
ate section of the application according to login creden-
tials. PMs enter baseline data, including the exam
screening form, into customized logic-based electronic
forms that provide validation checks to ensure partici-
pant eligibility prior to allocation.
Electronic data capture is used to collect PROs at 2, 4,
6, and 12 weeks from allocation (Table 2). Participants
are directed to the outcome assessments. Many features
were implemented to provide participants with a self-
managed experience while collecting study data at re-
spective intervals over the 12-week study period. Partici-
pants may complete the assessment from any device
capable of supporting an internet connection and web
browser. If a participant forgets or would like to change
their password, a link is provided that sends them a tem-
porary password to their email address. At the time of
the next login with the temporary password, STaRS will
prompt the user to define a new password for future
use. Within the STaRS application, participants may also
update their contact information at any time.
Outcome measures are collected in a linear manner
across all time points. Primary outcome measures are re-
quired variables and must be completed as a whole,
whereas secondary outcome measures may be skipped
by the participant. Programmatic review prompts the
users after each assessment for any missing variables
and asks them to review and complete them before
moving onto the next measure. A visual progress bar is
provided at the bottom of the page to inform users of
overall percent completed.
STaRS sends an email at pre-programmed intervals to
remind participants to complete the online assessments.
Outcome assessments are available to complete for a
window of 6 days for weeks 2 and 4, and 14 days for
weeks 6 and 12. Automated emails are programmed to
be sent the day the window opens for the respective
time point. An additional email will be sent by STaRS if
the participant has not completed the assessment by the
actual due date. To augment STaRS automated emails,
the PM personally contacts each participant by text mes-
sage, email, or telephone during the window for each as-
sessment. Participants can inform the site PM if they are
unable to access STaRS or complete the assessment for
various reasons. All contact with participants is docu-
mented by the site PM within STaRS.
If a participant does not complete an assessment
within the designated window (Table 2), a PM will at-
tempt to collect the primary outcome measures using a
computer-assisted telephone interview. A PM will at-
tempt to collect the week 2 and 4 assessments within
3 days, and the week 6 and week 12 assessments within
7 days of the assessment expiration dates.
For participants in the group that also receive chiro-
practic care, the DC completes a paper data collection
form for each study visit that details the type of spinal
manipulation performed including the anatomical
region, and other therapeutic procedures used with the
corresponding diagnosis (ICD-9) and procedural (CPT)
codes. The PM carefully tracks the number of study
visits per patient that occur in the 6-week period and
manages documentation for study visits. During the ac-
tive care phase of the trial, PMs enter data from the
Table 2 Data collection schedule
Assessment time point











Numeric Rating Scale for pain intensity X X X X X
Roland-Morris Disability Questionnaire X X X X X
Back Pain Functional Scale X X X X X
Bothersomeness of symptoms X X X X X
PROMIS-29 X X X
Global improvement measure X X X
Healthcare utilization and medication
use
X X X X X
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study treatment forms into customized electronic forms.
Data entry errors and change requests are submitted
through a module within STaRS that provides an audit
trail of who altered specific data elements and when they
were altered.
To document UMC received for LBP and to explore
healthcare utilization for LBP, information from health-
care provider visits for LBP that occur during the 12-
week study period is abstracted from the participant’s
electronic medical record. Data abstracted includes rea-
son for visit, provider type(s), diagnoses, procedures
conducted, and prescribed medications.
The dual purpose of the STaRS application allows for
trial management tools. STaRS is programmed to pro-
duce reports to allow study staff to monitor participants
through all phases of the study. Specific reports available
to study staff include a screening report, which provides
the number of participants screened as well as the rea-
sons for exclusion, and a tracking report, which allows
the user to view individual participant information such
as date of important study visits, allocation, and the sta-
tus of each outcome assessment. PMs can monitor
trends with respect to missed outcomes. PMs also enter
adverse events and protocol deviations into STaRS,
which is programmed to provide emails to specific study
investigators as well as research staff. This feature allows
for central investigator oversight, which is especially im-
portant given the multiple site locations.
Data management and security
The STaRS application is 21 CFR part 11 compliant and
integrated with a Central Participant Database and a
Project/Users Permissions System to control project
personnel access to web modules. PCCR registered the
backtoaction.org site secured with Certified Secure
Socket Layers (SSL) 128-bit encryption, hosted (IIS
V6.0), and maintained by Palmer College of Chiropractic
Information Services department. The web programmer
developed the application in ASP.NET v4.0 in C# and
Structured Query Language (SQL) using Microsoft Vis-
ual Studio 2010. All data are stored on an internal
Microsoft SQL Server 2014. Only select study personnel
have access to data via Microsoft SQL Server Manage-
ment Studio 2014. All PCCR servers reside behind a sta-
teful firewall with permissions determined by Active
Directory.
The data core manager will perform a soft lock of the
database (Microsoft SQL Server) and write programs in
SAS System for Windows (Release 9.3) using SAS AC-
CESS in order to perform data cleaning procedures of
range and consistency checks. Once all data edits are re-
corded and performed, the data core manager will co-
ordinate with the programmer to perform a final lock
removing all access to the database to ensure that no
further changes to the data can be made. Final
analyzable dataset(s) and the data dictionary will be cre-
ated from the final locked database.
Statistical methods
The data will be analyzed using an intention-to-treat ap-
proach in which participants will be analyzed according
to their original treatment allocation. All observed data
will be used in the analyses. Data analyses will be per-
formed using SAS/STAT (Release 9.3) (SAS Institute
Inc., Cary, NC).
Primary data analysis and sample size
The co-primary outcome variables (RMDQ and the NRS
for LBP intensity) will be modeled with linear mixed ef-
fects regression over baseline and weeks 2, 4, 6, and 12.
We will assume group means are the same at baseline,
and include terms in the model for time (as a categorical
variable), site, site-by-group, time-by-group, and site-by-
time-by-group interactions, and the variables in the
minimization algorithm. The covariance structure will
be chosen by comparing the maximized log-likelihoods
and the Bayesian information criteria for several covari-
ance pattern models against the unstructured covari-
ance. Diagnostics of the conditional predicted values and
conditional residuals will be used to assess the assump-
tion of normality and fit for each model.
The main results will be based on the final models for
the co-primary outcome variables at the end of the ac-
tive care phase (6 weeks). If the site-by-time-by-group
interaction is significant at the 0.05 level, results will be
reported by site. A p-value ≤ 0.025 will be used to deter-
mine if between group differences are statistically
significant.
Because the patient populations at the three sites are
different, we calculated a sample size of 106 per group
for each site to provide adequate power to detect clinic-
ally important differences between groups at each site.
The sample size estimates were obtained using a signifi-
cance level of 0.025 to account for 2 primary outcome
variables. The estimates of standard deviation (5.4 for
the RMDQ and 2.0 for the NRS for average pain inten-
sity over the past week) come from our pilot study [28].
This provides 80 % power to detect a 2.4 between group
difference on the RMDQ and 92 % power to detect a 1.2
difference on the NRS. In the pilot study, there was 13 %
and 11 % missing data in the UMC plus chiropractic
care group at the week 2 and 4 assessment periods, re-
spectively, but 39 % and 37 % in the UMC alone group.
We increased the sample size to 125 per group at
each site, assuming we would be able to keep our loss
to follow-up at the week 6 endpoint at or below
15 %, due to the implementation of intensive follow-
up procedures.
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Secondary evaluations of the final models will compare
group differences at week 12 to ascertain if the pattern
seen at week 6 remains after the active care phase.
Group differences will also be reported for week 2 and 4
to compare to the results of the pilot study. Secondary
analyses will compare the percentage of patients with
clinically meaningful improvement of at least 30 % rela-
tive to baseline at the week 6 endpoint on the co-
primary outcome variables [49]. General estimating
equations with a working covariance matrix will be used
to estimate the differences in proportions between
groups at each time point, with terms in the model for
time (as a categorical variable), group, site, site-by-
group, and time-by-group interactions, and the
minimization variables. Consistent with the recent NIH
Task Force recommendations [50] for a minimum data-
set for chronic LBP, we will conduct an exploratory ana-
lysis over a range of improvement levels.
Two approaches to sensitivity analyses will be used to
examine the possible effects of missing data on the re-
sults obtained from using all observed data for the co-
primary outcome variables. Prior to conducting the sen-
sitivity analyses, baseline variables that are predictive of
missing outcomes will be identified with logistic regres-
sion models. The first approach will be under the as-
sumption that data are missing at random and will use
the Markov chain Monte Carlo method to impute miss-
ing values for each of the primary outcome variables
based on the final mixed model covariates, the observed
outcome variable at baseline and weeks 2, 3, 6, and 12,
and the baseline variables predictive of missing data.
The resulting datasets for each of 20 imputations will be
analyzed with the linear mixed effects models that are fit
with all observed data and the results will be combined.
The second approach will be under the assumption that
data are missing not at random. It will follow the pattern
mixture approach described by Carpenter and Kenward
[51] by first imputing missing values as described above
for the missing at random approach and then for each
participant in each treatment group for each imputation.
The imputed observation will be decreased by different
amounts representing different patterns of responses.
The resulting datasets for each pattern will be analyzed
and the estimates combined as described above. If re-
sults differ between the analysis of the observed data
and that based on imputed full datasets under different
missingness assumptions, multiple sets of results will be
reported.
Secondary data analysis
The continuous secondary outcome variables will be an-
alyzed with linear mixed effects regression as described
above, but p-values ≤ 0.05 will be used to determine if
between group differences are significant. The ordinal
categorical variable representing the number of days that
participants reported using medications for LBP over the
past week will be analyzed over baseline and weeks 2, 3,
6, and 12 with a proportional odds model. Generalized
estimating equations using all observed data with a
working covariance structure will be used to fit the
model.
Protocol fidelity and quality assurance
Protocol fidelity
We are carefully tracking intervention and protocol ad-
herence. Using the Armed Forces Health Longitudinal
Technology Application, or patient electronic medical
record, we are tracking all care received for LBP during
the 3-month study duration. This includes both UMC
visits, as well as chiropractic visits. Instances where par-
ticipants who are allocated to receive UMC only but do
receive chiropractic care during the 6 weeks of active
care, as well as participants who are allocated to receive
chiropractic care but do not will be classified as
unanticipated events and documented in STaRS.
Internal quality assurance process
The lead PM conducts an internal quality assurance
audit at each site on a quarterly basis for the purpose of
maintaining data integrity, ensuring study protocol fidel-
ity, and standardizing study operating procedures across
all three sites. During the audit, the lead PM reviews
regulatory documentation and informed consent docu-
ments. Electronic data are verified by comparing the
paper source documents to the data entered in STaRS.
Any errors discovered during the quarterly audits are
documented, corrected by the site PM, and reported to
the site PI, collaborating investigators, and appropriate
regulatory bodies, if applicable.
During these site visits, the lead PM also meets with
site PMs, PIs, DCs, and/or clinic command to facilitate
communication about overall study status and discuss
study timelines, as well as address site concerns or bar-
riers interfering with study conduct. Information gath-
ered during the site visits is conveyed to study co-
investigators. In addition, the PCCR PI has a monthly
conference call with study personnel at each clinical site
to monitor study progress.
Study event monitoring and reporting
Adverse events
We have defined an adverse event as any untoward med-
ical occurrence presenting during the active study period
(6 weeks) that may or may not have a causal relationship
with study procedures [52]. A serious adverse event is
defined as an event resulting in a condition considered
as life-threatening, a congenital anomaly or birth defect,
in-patient hospitalization, disability, permanent damage,
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death, or an occurrence that requires intervention to
prevent death or significant disability. Adverse event in-
formation is being collected via 1) direct report to PM
and/or 2) self-report during online assessments.
Participants are encouraged to contact the PM if there
are any unplanned hospitalizations/procedures or for
any other health-related events whether or not the par-
ticipant considers them related to the study. When par-
ticipants report adverse event information directly to a
PM, the PM enters the adverse event information into
STaRS, which generates an auto-notification message to
the lead PM, designated trial clinician, and PI. Partici-
pants are also being prompted to answer questions
about adverse events during the week 2, 4, and 6 online
assessments. The lead PM and the central trial clinician
review adverse event information received from online
assessments on a weekly basis. The site PM will be asked
to follow up with any participant who reports an adverse
event to ascertain whether or not the event resulted in
hospitalization or appeared to be an unexpected reaction
or side effect from the study intervention. The lead PM
facilitates the submission of any reportable adverse
events to the respective IRBs, site medical monitor, and/
or the Data and Safety Monitoring Committee (DSMC).
Events not meeting the criteria for immediate reporting
are submitted to the IRBs at the time of continuing
review.
Each military study site has a medical monitor
assigned to the study. The medical monitor is respon-
sible for reviewing adverse events, as well as unantici-
pated events that may increase the risk to trial
participants, any related serious adverse event, or related
participant death. Events meeting these criteria are also
submitted to the DSMC and the U.S. Army Medical Re-
search and Material Command, Human Research Pro-
tection Office.
Study limitations
Given the nature of this trial, it is not possible to blind
either the treating clinicians or participants to treatment
assignment. This is an important limitation to this study.
However, all participants, clinicians, and study personnel
are blinded to next treatment assignment, and all key
study personnel and data analysts are blinded to group
assignment. One could also argue that the pragmatic na-
ture of this comparative effectiveness trial is a limitation
given the resulting lack of homogeneity in treatment ap-
proach both within and across groups. The advantage of
this approach is that the results are more applicable to
“real world practice”; the disadvantage is that one must
sacrifice the homogeneity inherent within an RCT.
We believe that a comparative effectiveness design is
the best way to answer questions that will be meaningful
to policy makers as they consider the appropriate role
for chiropractic care in active duty military populations.
Further, our experience in the conduct of clinical trials
in MTFs has shown us that this type of trial is feasible
to conduct in busy clinical practice settings. We will ad-
dress this limitation by collecting detailed data on the
treatments rendered to participants, for both analysis
and reporting purposes.
Discussion
Since LBP is one of the leading causes of disability
among U.S. military personnel, it is important to find
pragmatic and conservative treatments that will not only
treat LBP, but could ultimately preserve low back func-
tion so that military readiness is maintained. In this trial,
we will evaluate the effects of the addition of chiroprac-
tic care to UMC on LBP pain and disability. A pilot
study compared chiropractic care plus standard medical
care with standard medical care alone for active duty
military personnel with acute LBP [28]. Improvements
in pain and disability were significantly greater in the
chiropractic care group. This comparative effectiveness
study will evaluate whether these prior findings can be
reproduced in a larger sample, across multiple sites, and
with varied populations including individuals with sub-
acute and chronic LBP. The information gleaned from
this large, multisite trial may assist military healthcare
providers to more effectively treat a highly prevalent
condition responsible for high healthcare costs, debilitat-
ing effects on patients, and military readiness.
Trial status
Recruitment began in September of 2012. As of Novem-
ber 20, 2015, 750/750 participants were allocated and re-
cruitment was closed.
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